Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I care less to be a long or short term investor. As long as I make money it's all good. Can't quite see the end of tunel or the light with this one anymore. Just to many delays and changes. They hired ximedica to finish sport and now they changing it again. O well. Will be watching. Been in and out many times for small gain. :)
2018 or later for fda or ce. Wow
Love the way the board spends the buyer's money. Of course u would pay billions if u had it. Dream big :)
If buyout happened tomorrow we be lucky to get 200% premium from where pps is right know and they would include all outstanding warrants if they woud be in the money due to 200% premium. Imo .more shares smaller pps. Dream big
New corporate presentation ...
OilMinerDeluxe ... The new corporate presentation can be access via this site:
http://theralase.com/home-pages/theralase-corporate-presentation/
I'm awaiting a copy of it via my email inbox.
The timeframe looks like this, as per your post. Very interesting:
Pending:
2Q2016 - Health Canada Investigational Testing Authorization (ITA) Approval and commence enrolling patients into Health Canada Phase Ib clinical study for NMIBC
4Q2016 - FDA pre-Investigational New Drug Application (IND) Approval for NMIBC
1Q2017 - Commence enrolling patients into Health Canada Phase Ib clinical study for brain cancer and commence enrolling patients into FDA Phase Ib clinical study for lung cancer
2Q2017 - Complete Health Canada Phase Ib clinical study for NMIBC
3Q2017 - Commence enrolling subjects into Health Canada / FDA / CE Phase IIb clinical study for NMIBC
4Q2017 - FDA pre-Investigational New Drug Application (IND) Approval for lung and brain cancer
4Q2017 - Complete Health Canada Phase Ib clinical study for brain cancer and FDA Phase Ib clinical study for lung cancer
1Q2018 - Commence enrolling patients into Health Canada / FDA / CE Phase Ib clinical study for brain cancer and lung cancer
2Q2019 - Complete Health Canada / FDA / CE Phase IIb clinical study for NMIBC
4Q2020 - Complete Health Canada / FDA / CE Phase Ib clinical study for brain cancer and lung cancer Next Steps
Read more at http://www.stockhouse.com/companies/bullboard/v.tlt/theralase-technologies-inc#tKJ5P0s9vuGL5DyI.99
Please follow up and update us. Tia
Anybody?
Anyone?
O OK. Lol. learning a lot :)
Did anyone that lives in US currently successfully bought and exercised any of their warrants. Seems like long and hard procedure. Can it be done in us? I know I can buy but exercise seems imposible. Tia
TLT Business update...
We met with management at the Marcum Microcap Conference held in New York City (June 1-2, 2016). The topic of discussion was how ready is the market to adopt the TLC-2000 device as well as the progress on the Phase 1B clinical trial involving TLD-1433.
Since the approval from the FDA and Health Canada for the TLC-2000 device in December 2015, the market adoption of the device has been slow and uneven. A couple of reasons could be attributed to this choppiness. Although the new generation device is updated and has the feedback technology, customers appear to be notoriously slow to adopt this device as they opt to wait until the wrinkles are ironed out. Feedback from current customers is that they are comfortable and happy with the current device; if they had recently purchased a new device then they do not intend to invest in another device immediately and/or the features of the TLC-2000 do not interest them enough. Further, they are skeptical of investing in a newer device that is also 1.5-2x more expensive than the TLC-1000 device. These reasons seem to indicate that the TLC-2000 is not attractive enough to consumers to drive upgrades. Although this comes as a disappointment to Theralase it could be temporary and the company plans to train and educate their sales team to help accelerate market adoption. We think as healthcare practitioners gain experience using the TLC-2000, adoption times are likely to shorten.
Health Canada requires biocompatible, mechanical and sterility testing of the fibre optic components of the TLC-3200 medical laser which is used to activate TLD-1433 that is absorbed into bladder cancer lesions. Theralase’s application (Investigational Testing Application - ITA) is almost ready for submission to Health Canada and expected to happen by mid-June 2016. Approval could be obtained by Q2 2016 if an expedited review status (15 days for response) is granted. Otherwise, a response is provided within 30 calendar days from the date of submission. Enrollment in the Phase Ib NMIBC clinical trial at UHN will commence immediately following ITA approval. This could happen by end of July 2016.
In the Phase Ib NMIBC clinical study, the bladders of three patients will be instilled with a low dose of TLD-1433 drug and then light activated using the TLC-3200 medical laser. These three subjects will be monitored for 30 days to ensure safety and tolerability of the procedure. If no adverse events are reported, then an additional six subjects will be enrolled into the study who will be instilled with a high dose of TLD-1433 followed by light activation. They will be monitored for six months. If safety and tolerability of the procedure is demonstrated in all of the nine subjects, the Phase Ib study results will be used to support Health Canada approval and a Phase II multi-center efficacy study for NMIBC will commence in Q2 2017 in Canada, the U.S. and Europe.
Valuation
We have updated our financial model following Q1 2016 numbers as well as management’s guidance. The choppiness in our revenue forecast for 2016 and 2017 is based on the expected gain from the newly hired sales force and the variability in seasonal sales. We expect sales of the TLC-2000 device to pick up steam in 2H 2016 and anticipate Theralase to show improved performance on net income and cash flow from commercialization of the TLC-2000 device in the coming years. Our fundamentals and outlook on Theralase remain intact.
Read more at http://www.stockhouse.com/companies/bullboard/tltff/theralase-technologies-inc#zk2kt0uMjIp1X1GF.99
If this treatment only helps 25% of the treated people with no side effects Its a winner in my book. Ever little bit helps against this nasty cancer.
Nice base here. I like
Nice base here. I like
And look where intuitive is now even without the ones that don't know about DaVinci. I think Google's robot platform will blow competition out of the water. Imo
It's always one more month with these guys. O well. I'll wait and see what happens end of june. Waited this long won't give up now. As for revenuefrom tlc 2000 hopefully 2nd quarter be better. Never cared for that division. I want to see their pdc's helping people.
Just look at titan keeps changing timeliness and people blame the fda. In this company people blame HC for the delay. Ehhh
The market is also rigged. :) seen companies with huge potential go bankrupt due to shorts. Just saying. Have a great weekend and remember the one's that are gone.
Can't belive how many people follow titans story either on message board or Facebook twitter or linked-in and people keep on saying that the world does not know about titan. (Wait till the word gets out.) Lol . Not bashing just saying. What was the point of the big unveiling if they will change it again. At least i was under impression they were showing completed go to market product.
U belive everything you read on Internet. Lol. Do your own dd. Yes it is taking longer but most people have no idea how long it takes for a drug to get approved even to start trials. Sucks that they keep delaying it. I will wait to see it though. Still exited and added a little. The management should have done better job and foresee some of the delays and have this testing done before hand. But just like I am not perfect they are not perfect either. (I) decided to invest in tltff. Nobody forced me to it so in the end I will only blame myself if it turns out that I made a poor investment decision. ITA will come
(It's when not if. Cheers
Did u sell any titan shares yet? Been trading and I am back in black with titan. Can't post more than one post on that board. Been restricted to 1 a day for some reason. No freedom of speech over there for me.
Hope they can start the trials soon and prove it works. Can't wait. Would be awesome. Cancer sucks big time. Hope everyone on this board is doing well.
Watch and learn. Lol. Too me if there were partnership contact signed between verb or j&j and titan this thing would be flying even with the 2 year delay. Just doesn't seem like it. People talk and share price reflects the rumor. We'll wait and see. FYI gale biopharma has been good lately. Huge potential short term
If u build it they will come. NOT
Just picked up some more. Hopefully gets interesting soon. Waiting patiently.
Restrictions being lifted. What makes us think people will buy. Maybe they want to sell.
2 more years till sales. Hopefully. Geez. Let's show off sport at sages and than change it up again. Good work ximedica. (Slap in a face) They will have to adress outstanding share count and up list trough an rs sooner than later. Lots of time to make money somewhere else. Or some kind of market meltdown. Good luck to us all. 11out
I wish I could re listen to it again. I thought Jh did slip and say verb was the partner. Around 20 min Mark. I got really exited when I heard him say it. At least i thought he did .. Might be absolutely wrong. Verb and j&J stated last November that they are 2 years away from hitting the market
7 degrees of freedom. Just like titan. Surgeon station looks exactly like ours. In the pictures at least.
Just Google jack golden ximedica. Comes up as he is an employee.
Watch and learn he said. Lol
Nasdaq has to stay above $1 . Not sure about nyse